COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 288: Articles 2871-2880  | Next

Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
Waman, V. P., Ashford, P., Lam, S. D., Sen, N., Abbasian, M., Woodridge, L., Goldtzvik, Y., Bordin, N., Wu, J., Sillitoe, I., Orengo, C.
10.1101/2023.11.07.566012 — Posted: 2023-11-08
Allosteric modulation by the fatty acid site in the glycosylated SARS-CoV-2 spike
Oliveira, A. S. F., Kearns, F. L., Rosenfeld, M. A., Casalino, L. F., Berger, I., Schaffitzel, C., Davidson, A. D., Amaro, R. E., Mulholland, A. J.
10.1101/2023.11.06.565757 — Posted: 2023-11-08
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses
Bigotti, M. G., Klein, K., Gan, E. S., Anastasina, M., Andersson, S., Vapalahti, O., Katajisto, P., Erdmann, M., Davidson, A. D., Butcher, S. J., Collinson, I., Ooi, E. E., Balistreri, G., Brancaccio, A., Yamauchi, Y.
10.1101/2023.11.06.565781 — Posted: 2023-11-08
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
Gagne, M., Flynn, B. J., Andrew, S. F., Flebbe, D. R., Mychalowych, A., Lamb, E., Davis-Gardner, M. E., Burnett, M. R., Serebryannyy, L. A., Lin, B. C., Pessaint, L., Todd, J.-P. M., Ziff, Z. E., Maule, E., Carroll, R., Naisan, M., Jethmalani, Y., Case, J. B., Dmitriev, I. P., Kashentseva, E. A., Ying, B., Dodson, A., Kouneski, K., Doria-Rose, N. A., O'Dell, S., Godbole, S., Laboune, F., Henry, A. R., Marquez, J., Teng, I.-T., Wang, L., Zhou, Q., Wali, B., Ellis, M., Zouantchangadou, S., Van Ry, A., Lewis, M. G., Andersen, H., Kwong, P. D., Curiel, D. T., Foulds, K. E., Nason, M. C., Suthar, M. S., Roederer, M., Diamond, M. S., Douek, D. C., Seder, R. A.
10.1101/2023.11.06.565765 — Posted: 2023-11-08
Text Augmentations with R-drop for Classification of Tweets Self-Reporting Covid-19
Francis, S.
10.1101/2023.11.06.23298151 — Posted: 2023-11-07
Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in England
Manley, H., Bayley, T., Danelian, G., Burton, L., Finnie, T., Charlett, A., Watkins, N., Birrell, P., De Angelis, D., Keeling, M. J., Funk, S. J., Medley, G., Pellis, L., Baguelin, M., Ackland, G. J., Hutchinson, J., Riley, S., Panovska-Griffiths, J.
10.1101/2023.11.06.23298026 — Posted: 2023-11-07
ASSESSMENT AND CHARACTERIZATION OF COVID-19 RELATED COGNITIVE DECLINE: RESULTS FROM A NATURAL EXPERIMENT
Sekendiz, Z., Clouston, S., Morozova, O., Carr, M. A., Fontana, A., Mehta, N., Ali, A., Jiang, E., Luft, B. J.
10.1101/2023.11.06.23298101 — Posted: 2023-11-07
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2
Hoffmann, M., Willruth, L.-L., Dietrich, A., Lee, H. K., Knabl, L., Trummer, N., Baumbach, J., Furth, P. A., Hennighausen, L., List, M.
10.1101/2023.11.03.564190 — Posted: 2023-11-06
Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution
Foster, C. S. P., Walker, G. J., Jean, T., Wong, M., Brassil, L., Isaacs, S., Lu, Y., Turville, S. G., Kelleher, A., Rawlinson, W. D.
10.1101/2023.11.02.565396 — Posted: 2023-11-06
Voltage-gated T-type calcium channel blockers reduce apoptotic body-mediated SARS-CoV-2 cell-to-cell spread and subsequent cytokine storm
Phan, T. K., Sheerin, D., Shi, B., Dayton, M., Mackiewicz, L., Ozkocak, D. C., Atkin-Smith, G., Peton, N., Audi, O., Tixeira, R., Ashdown, G., Davidson, K. C., Doerflinger, M., Coussens, A. K., Poon, I. K. H.
10.1101/2023.11.03.565419 — Posted: 2023-11-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).